TY - JOUR
T1 - Sarcoidosis-related Uveitis
T2 - Clinical Presentation, Disease Course, and Rates of Systemic Disease Progression After Uveitis Diagnosis
AU - Ma, Shirley P.
AU - Rogers, Sophie L.
AU - Hall, Anthony J.
AU - Hodgson, Lauren
AU - Brennan, Jessica
AU - Stawell, Richard J.
AU - Lim, Lyndell L.
N1 - Funding Information:
Funding/Support: Centre for Eye Research Australia receives operational infrastructure support from the Victorian government. A/Prof Lim (GNT 1109330) is supported by a National Health and Medical Research Council (NHMRC) Early Career Fellowship (Australia). Financial Disclosures: The following authors have no financial disclosures: Shirley Ma, Sophie L. Rogers, Anthony J. Hall, Lauren Hodgson, Jessica Brennan, Richard Stawell, and Lyndell L. Lim. All authors attest that they meet the current ICMJE criteria for authorship.
Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2019/2
Y1 - 2019/2
N2 - Objective: To document the clinical presentation, treatment, and visual outcome of sarcoid uveitis and to determine the timing and potential risk factors of sarcoidosis progression to symptomatic systemic disease from the time of sarcoid uveitis diagnosis. Design: Retrospective, interventional case series. Methods: Subjects: Patients with dual diagnoses of uveitis and presumed/biopsy-proven sarcoidosis. Procedure: Retrospective review of 143 patient records from the Royal Victorian Eye and Ear Hospital and Eye Surgery Associates in Melbourne, Australia, between October 1990 and April 2014 coded with the dual diagnoses of uveitis and sarcoidosis. Only patients with uveitis and presumed or biopsy-proven sarcoidosis (N = 113) were included. Main Outcome Measures: Ascertainment of rate and time (months) to the development of symptomatic systemic sarcoidosis from uveitis onset; comparison of the patient demographics, characteristics of uveitis, treatment, and visual outcome between those who developed systemic sarcoidosis and those who remained systemically asymptomatic. Results: Uveitis was the initial presenting complaint of sarcoidosis in 78.8% (n = 89). Twenty-three patients had concurrent undiagnosed systemic disease at presentation and 29 subsequently developed symptomatic sarcoidosis in an organ uninvolved at uveitis onset. The median time to the development of symptomatic systemic sarcoidosis was 12 months. No statistically significant association was ascertained between any particular uveitis characteristic and extraocular sarcoidosis progression. Conclusion: Uveitis was the initial presentation of sarcoidosis in the vast majority of our subjects. Concurrent undiagnosed systemic sarcoidosis was common at the time of uveitis onset. A high index of suspicion for subsequent systemic progression should also be maintained, especially within the first 5 years of the uveitis diagnosis.
AB - Objective: To document the clinical presentation, treatment, and visual outcome of sarcoid uveitis and to determine the timing and potential risk factors of sarcoidosis progression to symptomatic systemic disease from the time of sarcoid uveitis diagnosis. Design: Retrospective, interventional case series. Methods: Subjects: Patients with dual diagnoses of uveitis and presumed/biopsy-proven sarcoidosis. Procedure: Retrospective review of 143 patient records from the Royal Victorian Eye and Ear Hospital and Eye Surgery Associates in Melbourne, Australia, between October 1990 and April 2014 coded with the dual diagnoses of uveitis and sarcoidosis. Only patients with uveitis and presumed or biopsy-proven sarcoidosis (N = 113) were included. Main Outcome Measures: Ascertainment of rate and time (months) to the development of symptomatic systemic sarcoidosis from uveitis onset; comparison of the patient demographics, characteristics of uveitis, treatment, and visual outcome between those who developed systemic sarcoidosis and those who remained systemically asymptomatic. Results: Uveitis was the initial presenting complaint of sarcoidosis in 78.8% (n = 89). Twenty-three patients had concurrent undiagnosed systemic disease at presentation and 29 subsequently developed symptomatic sarcoidosis in an organ uninvolved at uveitis onset. The median time to the development of symptomatic systemic sarcoidosis was 12 months. No statistically significant association was ascertained between any particular uveitis characteristic and extraocular sarcoidosis progression. Conclusion: Uveitis was the initial presentation of sarcoidosis in the vast majority of our subjects. Concurrent undiagnosed systemic sarcoidosis was common at the time of uveitis onset. A high index of suspicion for subsequent systemic progression should also be maintained, especially within the first 5 years of the uveitis diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=85056476272&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2018.09.013
DO - 10.1016/j.ajo.2018.09.013
M3 - Article
C2 - 30243930
AN - SCOPUS:85056476272
SN - 0002-9394
VL - 198
SP - 30
EP - 36
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
ER -